Cboe UK EUR
Moderna, Inc. (0QFD.XC)
22.90
-0.98
(-4.08%)
At close: May 30 at 2:42:24 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 13 | 13 | 25 | 25 |
Avg. Estimate | 116.85M | 1.16B | 2.07B | 2.41B |
Low Estimate | 67.8M | 789.74M | 1.57B | 1.36B |
High Estimate | 158M | 1.48B | 2.46B | 5.36B |
Year Ago Sales | 241M | 1.86B | 3.24B | 2.07B |
Sales Growth (year/est) | -51.51% | -37.97% | -35.88% | 16.16% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0QFD.XC | -- | -- | -- | -- |
S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
Maintains | JP Morgan: Underweight to Underweight | 5/22/2025 |
Maintains | UBS: Buy to Buy | 5/2/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 5/2/2025 |
Maintains | RBC Capital: Sector Perform to Sector Perform | 5/2/2025 |
Maintains | Evercore ISI Group: In-Line to In-Line | 5/2/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/9/2025 |